Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens (Q80796915)
scientific article published on 01 February 2006
Language:
(P31) (Q13442814)
(P304) 256-262
(P407) (Q1860)
(P433) 2
(P478) 1
(P577) Wednesday, February 1, 2006
(P1433) (Q15757929)
(P1476) "Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker" (language: en)
(P2093) Anastasia Chrysostomou
Eugenia Pedagogos
Lachlan MacGregor
Gavin J Becker
(P2860) (Q44847750)
(Q44280775)
other details
description scientific article published on 01 February 2006

External Links